The future of antibody fragments, made of a single immunoglobulin domain;Fragments d'anticorps à domaine unique: Les dAb, l'avenir des anticorps monoclonaux?

Medecine/Sciences

Volumn 25, Issue 12, 2009, Pages 1159-1161

  Chames, Patrick ^a   Baty, Daniel ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 74749088333     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200925121159     Document Type: Review

References (22)

1. Chames P, Van Regenmortel M, Weiss E, Baty D. Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol 2009 ; 157 : 220-33.
2. Ward ES, Gussow D, Griffiths AD, et al. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 1989 ; 341 : 544-6.
3. Hamers-Casterman C, Atarhouch T, Muyldermans S, et al. Naturally occurring antibodies devoid of light chains. Nature 1993 ; 363 : 446-8.
4. Greenberg AS, Avila D, Hughes M, et al. A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks. Nature 1995 ; 374 : 168-73.
5. Riechmann L, Muyldermans S. Single domain antibodies: comparison of camel VH and camelised human VH domains. J Immunol Methods 1999 ; 231 : 25-38.
6. Famm K, Hansen L, Christ D, Winter G. Thermodynamically stable aggregation-resistant antibody domains through directed evolution. J Mol Biol 2008 ; 376 : 926-31.
7. Dumoulin M, Conrath K, Van Meirhaeghe A, et al. Single-domain antibody fragments with high conformational stability. Protein Sci 2002 ; 11 : 500-15.
8. Tanaka T, Lobato MN, Rabbitts TH. Single domain intracellular antibodies: a minimal fragment for direct in vivo selection of antigen-specific intrabodies. J Mol Biol 2003 ; 331 : 1109-20.
9. Su C, Nguyen VK, Nei M. Adaptive evolution of variable region genes encoding an unusual type of immunoglobulin in camelids. Mol Biol Evol 2002 ; 19 : 205-15.
10. Vincke C, Loris R, Saerens D, et al. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J Biol Chem 2009 ; 284 : 3273-84.
11. Lauwereys M, Arbabi Ghahroudi M, Desmyter A, et al. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J 1998 ; 17 : 3512-20.
12. Stijlemans B, Conrath K, Cortez-Retamozo V, et al. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J Biol Chem 2004 ; 279 : 1256-61.
13. Goldman ER, Anderson GP, Liu JL, et al. Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library. Anal Chem 2006 ; 78 : 8245-55.
14. Roovers RC, Laeremans T, Huang L, et al. Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies. Cancer Immunol lmmunother 2007 ; 56 : 303-17.
15. Kubetzko S, Balic E, Waibel R, et al. PEGylation and multimerization of the anti-p185HER-2 single chain Fv fragment 4D5: effects on tumor targeting. J Biol Chem 2006 ; 281 : 35186-201.
16. Tijink BM, Laeremans T, Budde M, et al. Improved tumor targeting of anti-epidermal growth factor receptor nanobodies through albumin binding: taking advantage of modular nanobody technology. Mol Cancer Ther 2008 ; 7 : 2288-97.
17. Zhang J, Tanha J, Hirama T, et al. Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents. J Mol Biol 2004 ; 335 : 49-56.
18. Stone E, Hirama T, Tanha J, et al. The assembly of single domain antibodies into bispecific decavalent molecules. J Immunol Methods 2007 ; 318 : 88-94.
19. Behar G, Siberil S, Groulet A, et al. Isolation and characterization of anti-Fc gamma RIII (CD16) llama single-domain antibodies that activate natural killer cells. Protein Eng Des Sel 2008 ; 21 : 1-10.
20. Cortez-Retamozo V, Backmann N, Senter PD, et al. Efficient cancer therapy with a nanobody-based conjugate. Cancer Res 2004 ; 64 : 2853-7.
21. Miller TW, Messer A. Intrabody applications in neurological disorders: progress and future prospects. Mol Ther 2005 ; 12 : 394-401.
22. Wingren C, Borrebaeck CA. Progress in miniaturization of protein arrays: a step closer to high-density nanoarrays. Drug Discov Today 2007 ; 12 : 813-9.